KLRS
Kalaris Therapeutics, Inc.
$4.72+0.07 (1.51%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
2 of 12 tradesExecutives investing their own money
🤖AI Insight
Latest Insider Transactions
Showing 10 of 12 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | 2026-05-20 | Akkaraju Srinivas | Director | Other | 4,471 | $0.00 | $0 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Akkaraju Srinivas | Director | Other | 66,906 | $0.00 | $0 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Akkaraju Srinivas | Director | Other | 14,937 | $0.00 | $0 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Akkaraju Srinivas | Director | Purchase | 244,300 | $4.83 | $1,179,969 | +8.5% | N/A |
| 2026-03-23 | 2026-03-19 | Hagen Brett R | CAO | Award | 60,800 | $6.81 | $414,048 | N/A | N/A |
| 2026-03-23 | 2026-03-20 | Hagen Brett R | CAO | Sale | 1,915 | $6.72 | $12,869 | N/A | N/A |
| 2026-03-20 | 2026-03-19 | Oxtoby Andrew | See Remarks | Award | 222,000 | $6.81 | $1,511,820 | N/A | N/A |
| 2026-03-20 | 2026-03-19 | Gall Matthew | CFO | Award | 95,000 | $6.81 | $646,950 | N/A | N/A |
| 2026-03-20 | 2026-03-19 | Feinsod Matthew | CMO | Award | 135,000 | $6.81 | $919,350 | N/A | N/A |
| 2025-12-22 | 2025-12-22 | Akkaraju Srinivas | Director | Award | 1,500,000 | $10.00 | $15,000,000 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.